FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      ·

      abbv

      ·

      Cantor Fitzgerald Adjusts Price Target for AbbVie Ahead of Q1 Report

      Cantor Fitzgerald has revised its price target for AbbVie Inc. from $250 to $240 while maintaining an Overweight rating for the pharmaceutical company. This adjustment comes as the firm anticipates a lackluster earnings season for the first quarter, stating that it does not expect significant catalysts to rejuvenate investor interest in the sector.

      Despite the lowered price target, AbbVie is recognized as one of the 15 Best Cheap Dividend Stocks to Buy, highlighting its potential appeal to dividend-focused investors. The company's performance will be closely monitored as it approaches its upcoming Q1 earnings report.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud